Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers
Open Access
- 3 August 2015
- journal article
- Published by Peertechz Publications Private Limited in Journal of Addiction Medicine and Therapeutic Science
- Vol. 1 (2), 031-036
- https://doi.org/10.17352/2455-3484.000008
Abstract
Since its U.S. FDA approval in 2002, buprenorphine has been available for maintenance treatment of opiate dependence in primary care physicians' offices. Though buprenorphine was intended to facilitate access to treatment, disparities in utilization have emerged; while buprenorphine treatment is widely used in private care setting, public healthcare integration of buprenorphine lags behind. Through a review of the literature, we found that U.S. disparities are partly due to a shortage of certified prescribers, concern of patient diversion, as well as economic and institutional barriers. Disparity of buprenorphine treatment dissemination is concerning since buprenorphine treatment has specific characteristics that are especially suited for low-income patient population in public sector healthcare such as flexible dosing schedules, ease of concurrently treating co-morbidities such as HIV and hepatitis C, positive patient attitudes towards treatment, and the potential of reducing addiction treatment stigma. As the gap between buprenorphine treatment in public sector settings and private sector settings persists in the U.S., current research suggests ways to facilitate its dissemination.Keywords
This publication has 77 references indexed in Scilit:
- Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioidsDrug and Alcohol Dependence, 2012
- African American patients seeking treatment in the public sector: Characteristics of buprenorphine vs. methadone patientsDrug and Alcohol Dependence, 2012
- Collaborative Care of Opioid-Addicted Patients in Primary Care Using BuprenorphineJAMA Internal Medicine, 2011
- Effect of Incarceration History on Outcomes of Primary Care Office-based Buprenorphine/NaloxoneJournal of General Internal Medicine, 2010
- Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trialDrug and Alcohol Dependence, 2009
- Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative StudyJournal of General Internal Medicine, 2008
- Home Buprenorphine/Naloxone Induction in Primary CareJournal of General Internal Medicine, 2008
- Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and BarriersJournal of General Internal Medicine, 2008
- Availability of addiction medications in private health plansJournal of Substance Abuse Treatment, 2008
- Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone TreatmentJournal of General Internal Medicine, 2007